These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Staurosporine-based binding assay for testing the affinity of compounds to protein kinases. Iyer GH; Taslimi P; Pazhanisamy S Anal Biochem; 2008 Feb; 373(2):197-206. PubMed ID: 18047825 [TBL] [Abstract][Full Text] [Related]
9. Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A. Fernandez-Martinez J; Vela EM; Tora-Ponsioen M; OcaƱa OH; Nieto MA; Galceran J J Cell Sci; 2009 May; 122(Pt 10):1574-83. PubMed ID: 19383720 [TBL] [Abstract][Full Text] [Related]
10. New insights in covalent modifications of proteins and lipids: phosphorylation and beyond. Marette A Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E579-80. PubMed ID: 19176358 [No Abstract] [Full Text] [Related]
11. Structural biology: form and function instructions. Kelly JW Nature; 2005 Sep; 437(7058):486-7. PubMed ID: 16177774 [No Abstract] [Full Text] [Related]
12. Threonine phosphorylation times bacterial secretion. Kulasekara HD; Miller SI Nat Cell Biol; 2007 Jul; 9(7):734-6. PubMed ID: 17603507 [No Abstract] [Full Text] [Related]
13. Site-specific incorporation of glycosylated serine and tyrosine derivatives into proteins. Fahmi NE; Dedkova L; Wang B; Golovine S; Hecht SM J Am Chem Soc; 2007 Mar; 129(12):3586-97. PubMed ID: 17338522 [TBL] [Abstract][Full Text] [Related]
14. Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs. Lochhead PA; Sibbet G; Morrice N; Cleghon V Cell; 2005 Jun; 121(6):925-36. PubMed ID: 15960979 [TBL] [Abstract][Full Text] [Related]
15. Dyrk1A binds to multiple endocytic proteins required for formation of clathrin-coated vesicles. Murakami N; Bolton D; Hwang YW Biochemistry; 2009 Oct; 48(39):9297-305. PubMed ID: 19722700 [TBL] [Abstract][Full Text] [Related]
16. Molecular evolution of cystine-stabilized miniproteins as stable proteinaceous binders. Chang HJ; Hsu HJ; Chang CF; Peng HP; Sun YK; Yu HM; Shih HC; Song CY; Lin YT; Chen CC; Wang CH; Yang AS Structure; 2009 Apr; 17(4):620-31. PubMed ID: 19368895 [TBL] [Abstract][Full Text] [Related]
17. Cell size control: governed by a spatial gradient. Almeida R; Tyers M Dev Cell; 2009 Jul; 17(1):3-4. PubMed ID: 19619485 [TBL] [Abstract][Full Text] [Related]
18. Ser/Thr/Tyr phosphoproteome analysis of pathogenic and non-pathogenic Pseudomonas species. Ravichandran A; Sugiyama N; Tomita M; Swarup S; Ishihama Y Proteomics; 2009 May; 9(10):2764-75. PubMed ID: 19405024 [TBL] [Abstract][Full Text] [Related]
19. Comment on "Positive selection of tyrosine loss in metazoan evolution". Su Z; Huang W; Gu X Science; 2011 May; 332(6032):917; author reply 917. PubMed ID: 21596977 [TBL] [Abstract][Full Text] [Related]
20. QSAR analysis of pyrazolidine-3,5-diones derivatives as Dyrk1A inhibitors. Koo KA; Kim ND; Chon YS; Jung MS; Lee BJ; Kim JH; Song WJ Bioorg Med Chem Lett; 2009 Apr; 19(8):2324-8. PubMed ID: 19282176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]